Cartesian Therapeutics, Inc.'s (NASDAQ:RNAC) market cap rose US$14m last week; retail investors who hold 50% profited and so did insiders
Key Insights The considerable ownership by retail investors in Cartesian Therapeutics indicates that they collectively...